Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03016169 · ClinicalTrials.gov registry record · NA
Trifecta™ GT Post Market Clinical Follow-up
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 358
- Enrollment target
NCT03016169 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 358 participants.
The verdict
NCT03016169, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and performance of the Trifecta™ GT (Glide Technology) valve through 5 year follow-up in a prospective, multi-center, real-world setting. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.
Interventions
- DEVICE Trifecta GT (Glide Technology) Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03016169
The ClinicalTrials.gov registry entry for NCT03016169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trifecta GT (Glide Technology) Valve is the first listed.
NCT03016169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03016169 about?
NCT03016169 is a clinical study titled "Trifecta™ GT Post Market Clinical Follow-up". The objective of this study is to evaluate the safety and performance of the Trifecta™ GT (Glide Technology) valve through 5 year follow-up in a prospective, multi-center, real-world setting. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.
What is the current status of trial NCT03016169?
This trial is currently completed. It is a NA study. The enrollment target is 358 participants. The study started on 2017-03-09. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT03016169?
The interventions under investigation include: Trifecta GT (Glide Technology) Valve (DEVICE).
Who is sponsoring clinical trial NCT03016169?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.